Adult Tic Disorders Registry
RegisTICs
1 other identifier
observational
450
1 country
7
Brief Summary
The purpose of this study is to develop the adult tic disorders registry in order to characterize the relationship between tic severity and tic-related impairment in women compared to men with tic disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2021
Longer than P75 for all trials
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2021
CompletedFirst Posted
Study publicly available on registry
October 25, 2021
CompletedStudy Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
September 4, 2025
August 1, 2025
6 years
September 22, 2021
August 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation between Quality of Life and TICs severity
Severity of the tics measurement (YGTSS Impairment Score) and the quality of life (TS-QOL) between men and women with tic disorders, while controlling for the YGTSS Total Tic Score
6 months
Secondary Outcomes (1)
Change in TICs
6 months
Study Arms (1)
Quality of life questionnaires
Interventions
The scales (PUTS, OCI, TS-QOL, ASRS, GAD-7, PHQ9, TAPS) to be completed by the participant
Eligibility Criteria
Patient with tics disorders
You may qualify if:
- Age \>18 years
- Patients with Tic disorders
- Given the non-opposition
- No affiliation to a French health social insurance
- Significant congenital disorders that may affect understanding of assessments
- Patients under guardianship or curatorship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
CHU Limoges
Limoges, 87042, France
CHU Marseille
Marseille, 13003, France
Service de Neurologie, GH Pitié Salpêtrière
Paris, 75013, France
CHU Poitiers
Poitiers, 86000, France
CHU Nantes
Saint-Herblain, 44800, France
CHU Strasbourg
Strasbourg, 67200, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 22, 2021
First Posted
October 25, 2021
Study Start
December 1, 2021
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
September 4, 2025
Record last verified: 2025-08